These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 28498925
1. A case report of anaphylaxis to Typhoid Vaccine Live Oral Ty21a (Vivotif). Haas NL, Haas MRC, Gregory C. J Travel Med; 2017 Sep 01; 24(5):. PubMed ID: 28498925 [Abstract] [Full Text] [Related]
2. Patient compliance in the use of Vivotif Berna(R) vaccine, typhoid vaccine, live oral Ty21a. Wiedermann G. J Travel Med; 1998 Mar 01; 5(1):1-2. PubMed ID: 9772307 [No Abstract] [Full Text] [Related]
10. Typhoid vaccines. Aggarwal A, Dutta AK. Indian J Pediatr; 2001 Aug 09; 68(8):733-6. PubMed ID: 11563251 [Abstract] [Full Text] [Related]
11. Compliance to live oral Ty21a typhoid vaccine, and its effect on viability. Stubi CL, Landry PR, Pétignat C, Bille J, Genton B, Darioli R, Burnier M. J Travel Med; 2000 Aug 09; 7(3):133-7. PubMed ID: 11179942 [Abstract] [Full Text] [Related]
12. Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated p6olera CVD103-HgR and typhoid ty21a vaccines. Tsai TF, Kollaritsch H, Que JU, Cropp CB, Kunz C, Wiedermann G, Herzog C, Cryz SJ. J Infect Dis; 1999 Feb 09; 179(2):522-4. PubMed ID: 9878043 [No Abstract] [Full Text] [Related]
13. Comment on: evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh. Arya SC, Agarwal N. Vaccine; 2014 Jul 07; 32(32):4013. PubMed ID: 24831232 [No Abstract] [Full Text] [Related]
14. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever. Fraillery D, Baud D, Pang SY, Schiller J, Bobst M, Zosso N, Ponci F, Nardelli-Haefliger D. Clin Vaccine Immunol; 2007 Oct 07; 14(10):1285-95. PubMed ID: 17687110 [Abstract] [Full Text] [Related]
16. A Japanese study to assess immunogenicity and safety of a typhoid Vi polysaccharide vaccine. Miyazu M, Kikuchi H, Hamada A, Fukushima S, Ouchi K, Bosch Castells V, Mihara H, Bonnet MC. Vaccine; 2015 Nov 27; 33(48):6697-702. PubMed ID: 26518404 [Abstract] [Full Text] [Related]
17. Vivotif--a 'magic shield' for protection against typhoid fever and delivery of heterologous antigens. Gentschev I, Spreng S, Sieber H, Ures J, Mollet F, Collioud A, Pearman J, Griot-Wenk ME, Fensterle J, Rapp UR, Goebel W, Rothen SA, Dietrich G. Chemotherapy; 2007 Nov 27; 53(3):177-80. PubMed ID: 17347563 [Abstract] [Full Text] [Related]
18. Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study. Mitra M, Shah N, Ghosh A, Chatterjee S, Kaur I, Bhattacharya N, Basu S. Hum Vaccin Immunother; 2016 Apr 02; 12(4):939-45. PubMed ID: 26901576 [Abstract] [Full Text] [Related]
19. Response on letter by Arya et al.: "evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh.". Bhuiyan TR, Choudhury FK, Khanam F, Saha A, Sayeed MA, Salma U, Qadri F, Lundgren A, Svennerholm AM, Sack DA. Vaccine; 2014 Jul 07; 32(32):4014. PubMed ID: 24837778 [No Abstract] [Full Text] [Related]
20. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide. Tacket CO, Pasetti MF, Sztein MB, Livio S, Levine MM. J Infect Dis; 2004 Aug 01; 190(3):565-70. PubMed ID: 15243933 [Abstract] [Full Text] [Related] Page: [Next] [New Search]